You are here: Industry Insights > Vaccine

News List

COVID-19 containment shaped by strength, duration of natural, vaccine-induced immunity worldpharmanews
October 28, 2020
"Much of the discussion so far related to the future trajectory of COVID-19 has rightly been focused on the effects of seasonality and non-pharmaceutical interventions [NPIs], such as mask-wearing and physical distancing," said co-first author ...
Peru refuses Covid-19 vaccine purchase deal with AstraZeneca pharmaceutical-technology
October 26, 2020
The Peruvian government has refused to sign an agreement with AstraZeneca to purchase coronavirus vaccine as the latter failed to provide sufficient data from its studies.
Envirotainer Adds 57% more RAP e2 capacity in the US prnasia
October 22, 2020
Envirotainer, the global market leader and by far largest provider of temperature-controlled air freight solutions for pharmaceuticals, announced that they are increasing their RAP e2 network capacity in the US by 57%.
UK to establish human challenge studies for COVID-19 vaccines europeanpharmaceuticalreview
October 22, 2020
The UK government hopes to expedite the development of a COVID-19 vaccine by investing £33.6 million in the first phase of establishing human challenge trials.
GSK to begin final-stage trials of respiratory syncytial virus vaccine expresspharma
October 22, 2020
GlaxoSmithKline said it would move its experimental vaccine against the respiratory syncytial virus (RSV), a cause of pneumonia in toddlers and the elderly, into the final stage of testing, encouraged by mid-stage trial results.
First results of Russian coronavirus vaccine trial may include data from 5,000-10,000 people expresspharma
October 22, 2020
Preliminary results from the late-stage human trial of Russia’s main coronavirus vaccine candidate could include data from 5,000-10,000 participants, Denis Logunov, a director at the Gamaleya Institute that developed the vaccine, said on Monday.
Experts partner with UK government for COVID-19 human challenge trials pharmatimes
October 22, 2020
The UK government has joined forces with experts from the NHS, academia and the private sector to explore and establish human challenge trials to aid the development of a COVID-19 vaccine.
Vaccine trials outside home market will help Chinese firms capture Asia, South and Central America markets: GlobalData expresspharma
October 19, 2020
Pharma companies across the globe are working to develop a vaccine against COVID-19, which has already infected more than 38 million globally.
Vaccine delivery system should involve all levels of governments and citizen groups: PM Modi expresspharma
October 19, 2020
He stressed that every step in the logistics, delivery, and administration should be put in place rigorously.
Confidence in reliability of data regarding COVID-19 therapies remains moderately high: Poll pharmaceutical-technology
October 16, 2020
The need for a therapy to combat the contagious coronavirus disease (COVID-19) has led pharmaceutical companies to fast-track development plans, raising concerns over safety data.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page